文献速递静脉血栓栓塞慢性静脉疾病

混合抗凝及既往静脉血栓患者血浆因子VIII水平升高分析

Elevated plasma factor VIII levels in a mixed patient population on anticoagulation and past venous thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-12-16

回顾性分析2019年全年306例在静脉专科门诊行血栓倾向面板检测的患者,按因子VIII水平分为正常组(≤150 IU/dL,n=92)和升高组(>150 IU/dL,n=214)。升高组家族性DVT史、无诱因DVT及静脉溃疡比例更高,且因子VIII>150 IU/dL为DVT发生的显著预测因子,>200 IU/dL为DVT复发(≥2次)的显著预测因子。

要点

  • 因子VIII>150 IU/dL是DVT发生的显著预测因子(OR 3.3,P<.005)。
  • 因子VIII>200 IU/dL是DVT复发(≥2次)的显著预测因子(OR 12.3,P<.005)。
  • 因子VIII升高组中无诱因DVT、家族性DVT史及静脉溃疡比例显著更高。

核心结论

  • 在接受血栓倾向检测的静脉专科患者中,相当比例存在因子VIII升高,且升高与静脉溃疡、DVT家族史及无诱因DVT相关。
  • 因子VIII>200 IU/dL与DVT复发相关,对DVT二级预防策略有重要意义。

研究设计与样本

  • 回顾性分析2019年1月至12月共306例在三级医院静脉专科门诊行血栓倾向面板并检测血浆因子VIII水平的患者记录。
  • 按因子VIII水平分组:正常组(≤150 IU/dL,n=92)与升高组(>150 IU/dL,n=214)。

主要发现

  • 正常组与升高组中位年龄分别为55岁和65岁。
  • DVT家族史在正常组为6例(6.5%),升高组为77例(36%),P=.0001。
  • 无诱因DVT在升高组为66%,正常组为5%,P=.0001;静脉溃疡在升高组为23%,正常组为11%,P=.008。
  • 因子VIII>150 IU/dL预测DVT发生(OR 3.3,P<.005);>200 IU/dL预测≥2次DVT发作(OR 12.3,P<.005)。

关键数值与推荐

  • 因子VIII升高定义为>150 IU/dL;正常定义为≤150 IU/dL。
  • 静脉血栓栓塞事件若与手术、创伤、制动、骨科骨折、围产期或激素使用相关则归类为诱因性,否则为无诱因性。

临床怎么用

  • 对静脉专科门诊行血栓倾向检测的患者,应关注因子VIII水平,尤其>150 IU/dL者需评估DVT风险。
  • 因子VIII>200 IU/dL提示DVT复发风险高,可考虑强化二级预防策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thrombophilia conditions are associated with an increased risk of venous thromboembolism. Elevated plasma levels of factor VIII (>150 IU/dL) increase the risk of venous thrombosis. The aim of this report is to analyze a subset of patients in whom plasma factor VIII levels were investigated as part of a thrombophilia panel at a specialty venous clinic at a tertiary care hospital. METHODS: From January 2019 to December 2019, records of all patients (n = 306) who had a plasma factor VIII level assay performed as part of a thrombophilia panel were retrospectively analyzed. Group 1 (n = 92) had normal factor VIII levels (≤150 IU/dL), whereas group 2 (n = 214) had elevated factor VIII levels (>150 IU/dL). Venous thromboembolic events were classified as provoked if there was an association with surgery, trauma, immobilization, orthopedic fracture, peripartum period, or use of hormones. If there was no associated factor identifiable in the patient's history, the event was considered unprovoked. RESULTS: The median age for patients in groups 1 and 2 was 55 and 65 years, respectively. Family history of deep venous thrombosis (DVT) was noted in 6 patients in group 1 (6.5%) vs 77 patients in group 2 (36%), P value: .0001. Unprovoked DVT was more commonly noted in group 2 patients (66%) compared with group 1 patients (5%), P value: .0001. In addition, venous ulceration was more commonly encountered in group 2 (23%) than group 1 (11%), P value: .008. Factor VIII level >150 IU/dL was a significant predictor of DVT occurrence itself (odds ratio: 3.3, P value <.005). Factor VIII level >200 IU/dL was a significant predictor of occurrence of two or more episodes of DVT (odds ratio: 12.3, P value < .005). CONCLUSIONS: Factor VIII levels were found to be elevated in a significant proportion of patients in whom thrombophilia testing was performed at a specialty venous clinic. This elevation was more common in patients with venous ulceration, a positive family history of DVT, and a personal history of an unprovoked DVT. Levels above 200 IU/dL were associated with DVT recurrence. This has important implications for secondary prophylactic strategies for DVT.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Saleem T, Burr B, Robinson J, et al. Elevated plasma factor VIII levels in a mixed patient population on anticoagulation and past venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33340732. doi:10.1016/j.jvsv.2020.12.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。